EUVIMEDEUVIMED entdecken
Open Access

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network ( LUMEN )

Alain Sanchez-Rodriguez iD, Jose Antonio Meade-Aguilar iD, Jeffrey X Yang, Gabriel Figueroa-Parra iD, Andrew C Hanson, Hannah E Langenfeld, Uma Thanarajasingam, Alanna M Chamberlain iD, Kurt J Greenlund, Kamil E Barbour iD, Cynthia S Crowson iD, Alí Duarte-García iD

Arthritis Care & Research · 2025

DOI: 10.1002/acr.25445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Alain Sanchez-Rodriguez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Time-to-Treatment, Health Services Accessibility, Critical Pathways. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCDPHP CDC HHS, NCATS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to characterize presentation and care pathways of patients with systemic lupus erythematosus (SLE), and delays in access to SLE‐specialized care.

Methods

We included patients with incident SLE from the Lupus Midwest Network registry. Time from the first medical encounter for SLE clinical manifestation to access to SLE‐specialized care, physician diagnosis, and treatment was estimated. Delays were defined as ≥6 months to access specialized care. We compared SLE manifestations, disease activity, and Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage indexes (SDI) between patients with and without delays. Logistic regression models assessed associations with delays.

Results

The study included 373 patients with SLE. The median time to access SLE‐specialized care was 1.1 (95% confidence interval [CI] 0.9–1.5) months, time to diagnosis was 30.6 (95% CI 18.9–48.1) months, and time to treatment initiation was 4.7 (95% CI 3.9–8.4) months. Approximately 25% of patients (93 out of 373) experienced delays accessing specialized care, which were associated with fewer SLE manifestations at first SLE‐related encounter (fewer than two SLE domains; 92% vs 72%, P < 0.001). Patients with mucocutaneous or musculoskeletal manifestations were less likely to experience delays, whereas hematologic (odds ratio [OR] 1.71, 95% CI 1.03–2.84) or antiphospholipid antibodies domains (OR 6.05, 95% CI 2.46–14.88) were associated with delays. Delays were associated with damage at first access to SLE‐specialized care (SDI ≥1; 30% vs 7%, P < 0.001).

Conclusion

Patients follow a heterogeneous pathway to receive care. One‐fourth of patients experienced delays accessing SLE‐specialized care, which was associated with disease‐related damage. Fewer manifestations, hematologic manifestations, or antiphospholipid antibodies were associated with delays. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicTime-to-TreatmentHealth Services AccessibilityCritical PathwaysHumansFemaleMaleAdultMiddle AgedRegistriesTime FactorsYoung AdultMidwestern United States

Autor:innen und Institutionen

  • Mayo Clinic, Rochester, Minnesota.
  • Centers for Disease Control and Prevention, Atlanta, Georgia.

ORCID-Profile: Alain Sanchez-Rodriguez, Jose Antonio Meade-Aguilar, Gabriel Figueroa-Parra, Alanna M Chamberlain, Kamil E Barbour, Cynthia S Crowson, Alí Duarte-García

Förderung

  • NCCDPHP CDC HHS
  • NCATS NIH HHS
  • NIA NIH HHS
  • Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS)
  • National Center for Advancing Translational Sciences
  • National Institute on Aging

Zitieren

APA

Sanchez-Rodriguez, A., Meade-Aguilar, J. A., Yang, J. X., Figueroa-Parra, G., Hanson, A. C., Langenfeld, H. E., Thanarajasingam, U., Chamberlain, A. M., Greenlund, K. J., Barbour, K. E., Crowson, C. S., & Duarte-García, A. (2025). Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network ( LUMEN ). Arthritis Care & Research. https://doi.org/10.1002/acr.25445

Vancouver

Sanchez-Rodriguez A, Meade-Aguilar JA, Yang JX, Figueroa-Parra G, Hanson AC, Langenfeld HE, et al. Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network ( LUMEN ). Arthritis Care & Research. 2025. doi:10.1002/acr.25445

BibTeX
@article{SanchezRodriguez2025,
  author = {Sanchez-Rodriguez, Alain and Meade-Aguilar, Jose Antonio and Yang, Jeffrey X and Figueroa-Parra, Gabriel and Hanson, Andrew C and Langenfeld, Hannah E and Thanarajasingam, Uma and Chamberlain, Alanna M and Greenlund, Kurt J and Barbour, Kamil E and Crowson, Cynthia S and Duarte-García, Alí},
  title = {Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network ( LUMEN )},
  journal = {Arthritis Care & Research},
  year = {2025},
  doi = {10.1002/acr.25445}
}
Kostenlos starten →